Circulating Levels of a Collagen Type V Propeptide Fragment in a Carbon Tetrachloride Reversible Model of Liver Fibrosis

by E. Vassiliadis, S.S. Veidal, C. Hansen, M.A. Karsdal, D.J. Leeming
Published 2012-01-01

Circulating Levels of a Collagen Type V Propeptide Fragment in a Carbon Tetrachloride Reversible Model of Liver Fibrosis

by E. Vassiliadis, S.S. Veidal, C. Hansen, M.A. Karsdal, D.J. Leeming
Published 2012-12-01

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis

by H. Jessen, N. Hoyer, T. S. Prior, P. Frederiksen, M. A. Karsdal, D. J. Leeming, E. Bendstrup, J. M. B. Sand, S. B. Shaker
Published 2021-07-01

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker

by S.N. Kehlet, C.L. Bager, N. Willumsen, B. Dasgupta, C. Brodmerkel, M. Curran, S. Brix, D.J. Leeming, M. A. Karsdal
Published 2017-08-01

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis

by D.J. Leeming, N. Willumsen, J.M.B. Sand, S. Holm Nielsen, B. Dasgupta, C. Brodmerkel, M. Curran, C.L. Bager, MA. Karsdal
Published 2019-03-01

Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis

by D. J. Leeming, F. Genovese, J. M. B. Sand, D. G. K. Rasmussen, C. Christiansen, G. Jenkins, T. M. Maher, J. Vestbo, M. A. Karsdal
Published 2021-02-01